Original Article

Analysis of HLA Antigens in Turkish Sarcoidosis Patients

Authors: Muammer Bilir, MD, Sevtap Sipahi, MD, Erkan Yilmaz, PhD, Kenan Midilli, MD, Halil Yanardag, MD, Tulin Cagatay, MD, Sabriye Demirci, MD, Tuncer Karayel, MD, Ergun Erdogan, MD

Abstract

Background: Sarcoidosis is a systemic granulomatous disorder associated with high CD4+cell activity, without any detectable pathogen. Clustering in families occurs, and the existence of a genetic predisposition to sarcoidosis is widely accepted. There are differences among different ethnic groups.


Methods: We studied HLA polymorphisms in 64 Turkish patients with biopsy proven sarcoidosis. The control group was taken of 160 donor candidates of kidney transplantation within the same period.


Results: Fifty-one patients were female, and 13 were male. The mean age was 39 ± 6.1 years. Frequency of HLA A2, A9, A24 (9), A25, A69 (28), B12, B22, B38, B49 (21), DR4, and DR14 antigens were significantly higher, and frequencies of HLA B7 and DR7 were significantly less in sarcoidosis patients. Clustering in some families were also noted in our study.


Conclusions: This study implies a genetic predisposition to sarcoidosis in the Turkish population. Clustering in some families should be kept in mind.


Key Points


* Some epidemiological data including clustering in families suggest a genetic predisposition to sarcoidosis.


* A significant difference among the frequency of some HLA antigens is noted in Turkish sarcoidosis patients.


* The difference among the frequencies of HLA antigens in sarcoidosis is not universal and may differ in nations.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References

1. Schurmann M, Lympany PA, Reichel P, et al. Familial sarcoidosis is linked to the major histocompatibility complex region. Am J Respir Crit Care Med 2000;162:861–864.
 
2. Thomas PD, Hunninghake GW. Current concepts of the pathogenesis of sarcoidosis. Am Rev Respir Dis 1987;135:747–760.
 
3. Tiwari JL, Terasiki PI. HLA and Disease Association. New York: Springer-Verlag, 1985;380–381.
 
4. Abe S, Yamaguchi E, Makimura S, et al. Association of HLA DR with sarcoidosis: correlation with clinical course. Chest 1987;92:488–490.
 
5. Martinetti M, Tinelli C, Kolek V, et al. The sarcoidosis map: a joint survey of clinical and immunogenetic findings in two European countries. Am Respir Crit Care Med 1995;152:557–564.
 
6. De Remee RA. The roentgenographic staging of sarcoidosis: historic and contemporary perspectives. Chest 1983;83:128–133.
 
7. Terasaki PI, McCleland JD. Microdroplet assay of human serum cytotxins. Nature 1964;204:998–1000.
 
8. Akokan G, Celikoglu S, Goksel FM, et al. Antigens in Turkish patients with sarcoidosis. N Engl J Med 1977;296:759.
 
9. Celik G, Sen E, Ulger AF, et al. Human leukocyte antigens A and B in Turkish patients with sarcoidosis [in Spanish]. Arch Bronchoneumol 2004;40:449–452.
 
10. Odum N, Milman N, Jakobsen BK, et al. HLA class II (DR, DP, DQ) in patients with sarcoidosis: evidence of an increased frequency of DRw6. Exp Clin Immunogenet 1991;8:227–232.
 
11. Lenhart K, Kolek V, Bartova A. HLA antigens associated with sarcoidosis. Dis Markers 1990;8:23–29.
 
12. Kunikane H, Abe S, Tsuneta Y, et al. Role of HLA DR antigens in Japanese patients with sarcoidosis. Am Rev Respir Dis 1987;135:688–691.
 
13. Berlin M, Fogdell-Hahn A, Olarup O, et al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med 1997;156:1601–1605.
 
14. Pasturenzi L, Martinentti M, Cuccia M, et al. HLA class I, II and III polymorphism in Italian patients with sarcoidosis: the Pavia-Padora Sarcoidosis Study Group. Chest 1993;104:1170–1175.